There may be options after failure of CAR T-cell therapy. #CBCI is opening an anti CD20-CD3 therapy soon...stay tuned #lymphoma

TIGIT study is currently enrolling for #myeloma and #lymphoma patients CBCI #CBCI #TCTM20

Congrats!!!

Cord blood can be used to treat more than 80 diseases,including blood cancers like leukemia & lymphoma. Learn more: p.ctx.ly/r/1tpx

Porter: Relapsed ALL a great target for CAR T-cells #BMTTandem16

More than 8600 patients enrolled in BMT CTN trials in 11 years!#BMTTandem16 #bmtsm CIBMTR

CIBMTR encouraging to see outcomes improving for patients 70+years who've had an allogeneic transplant #BMTTandem16 bit.ly/1T0Ewke

FDA Grants Midostaurin Breakthrough Designation for AML shar.es/1CniVC via OncLive.com #ASH15

Because of your support, these numbers continue to rise! #hodgkinlymphoma #SomedayisToday

LLS Rocky Mountain Blood Cancer Conference today! Snowstorms can't keep away all our amazing patients. Thank you 伊藤佑愛 CBCI

ASCO. Meta analysis shows revlimid maint emac after asct improves Overall survival dramatically

Dasatinib + Low-Intensity Chemo Results in Long-Term Survival for Older Patients with Ph+ ALL ow.ly/PevY300Y6p8 via ASH Clinical News

More compelling pre-clinical data on the possible role of HDAC inhibition in #lymphoma #ASHMLB16

Patients will tell other patients things they won't tell HCP or caregivers. #Mentoring is key. #NIHBMTLateEffects x.com/bldcancerdoc/s…

Caregiver support groups available CBCI. A safe place for participants to discuss unique #BMT stressors x.com/bmtinfonet/sta…

One of our CBCI, Dr Richard Nash, discussing the use of autologous HCT in the treatment of #MultipleSclerosis and other autoimmune diseases at #BMTTandem18

Dr. Nash reviewed data for autologous transplant for multiple sclerosis and announced the exciting future phase 3 study (BEAT MS) which will not use CD34 Selection and it will be done in collbration with BMT CTN